These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24965824)

  • 21. Non-steroidal and non-cytotoxic therapies for nephrotic syndrome.
    Coppo R
    Nephrol Dial Transplant; 2008 Jun; 23(6):1793-6. PubMed ID: 18441003
    [No Abstract]   [Full Text] [Related]  

  • 22. Rituximab in steroid-dependent nephrotic syndrome.
    El Koumi M
    Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
    Sellier-Leclerc AL; Baudouin V; Kwon T; Macher MA; Guérin V; Lapillonne H; Deschênes G; Ulinski T
    Nephrol Dial Transplant; 2012 Mar; 27(3):1083-9. PubMed ID: 21810762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J; Du J; Wang S; Xiao L; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab in steroid-resistant nephrotic syndrome in children: a (false) glimmer of hope?
    Pradhan M; Furth S
    J Am Soc Nephrol; 2012 Jun; 23(6):975-8. PubMed ID: 22581992
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeted therapies: Is there a role for rituximab in nephrotic syndrome?
    Feehally J
    Nat Rev Nephrol; 2014 May; 10(5):245-7. PubMed ID: 24614409
    [No Abstract]   [Full Text] [Related]  

  • 27. Rituximab in childhood lupus myocarditis.
    Aggarwal P; Singh S; Suri D; Rawat A; Narula N; ManojKumar R
    Rheumatol Int; 2012 Jun; 32(6):1843-4. PubMed ID: 21468728
    [No Abstract]   [Full Text] [Related]  

  • 28. Rituximab for steroid-dependent nephrotic syndrome.
    Beco A; Castro-Ferreira I; Coentrao L; Neto R; Sampaio S; Pestana M
    Clin Nephrol; 2010 Oct; 74(4):308-10. PubMed ID: 20875384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rituximab for the treatment of nephrotic syndrome].
    Iijima K
    Nihon Jinzo Gakkai Shi; 2014; 56(4):471-7. PubMed ID: 24956878
    [No Abstract]   [Full Text] [Related]  

  • 30. Ofatumumab for rituximab-resistant nephrotic syndrome.
    Basu B
    N Engl J Med; 2014 Mar; 370(13):1268-70. PubMed ID: 24670185
    [No Abstract]   [Full Text] [Related]  

  • 31. [Idiopathic nephrotic syndrome in children: from corticosteroids to rituximab].
    Deschênes G
    Arch Pediatr; 2011 Aug; 18(8):843-5. PubMed ID: 21719260
    [No Abstract]   [Full Text] [Related]  

  • 32. Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome.
    Czarniak P; Załuska-Leśniewska I; Zagożdżon I; Zurowska A
    Pediatr Nephrol; 2013 Jun; 28(6):987-8. PubMed ID: 23549855
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
    Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A
    Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppressive therapies for refractory nephrotic syndrome].
    Mitarai T
    Nihon Jinzo Gakkai Shi; 2010; 52(7):924-7. PubMed ID: 21077342
    [No Abstract]   [Full Text] [Related]  

  • 35. [Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].
    Imai E
    Nihon Jinzo Gakkai Shi; 2012; 54(5):593-7. PubMed ID: 22991838
    [No Abstract]   [Full Text] [Related]  

  • 36. Critical evaluation of rituximab rescue in 27 patients with different types of kidney disease.
    Ganzemueller J; Hartmann B; Keller F; Stracke S
    Minerva Urol Nefrol; 2011 Dec; 63(4):263-72. PubMed ID: 21996981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
    Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
    G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab in treatment of idiopathic glomerulopathy.
    El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of rituximab treatment in children with primary glomerulonephritis.
    Zachwieja J; Silska M; Ostalska-Nowicka D; Soltysiak J; Lipkowska K; Blumczynski A; Musielak A
    J Nephrol; 2012; 25(6):1060-6. PubMed ID: 22322817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.
    Mellon-Reppen S; Ratanatharathorn V; Cronin S; Uberti JP
    Bone Marrow Transplant; 2010 Dec; 45(12):1758-9. PubMed ID: 20383208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.